Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
JYNT logo

The Joint Corp (JYNT)JYNT

Upturn stock ratingUpturn stock rating
The Joint Corp
$11.35
Delayed price
Profit since last BUY-9.78%
WEAK BUY
upturn advisory
BUY since 8 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

11/20/2024: JYNT (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: WEAK BUY
Historic Profit: 0.2%
Upturn Advisory Performance Upturn Advisory Performance2
Avg. Invested days: 32
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 11/20/2024
Type: Stock
Today’s Advisory: WEAK BUY
Historic Profit: 0.2%
Avg. Invested days: 32
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 11/20/2024
Upturn Advisory Performance Upturn Advisory Performance2

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 164.07M USD
Price to earnings Ratio -
1Y Target Price 16.38
Dividends yield (FY) -
Basic EPS (TTM) -1.14
Volume (30-day avg) 54065
Beta 1.58
52 Weeks Range 8.60 - 17.82
Updated Date 11/20/2024
Company Size Small-Cap Stock
Market Capitalization 164.07M USD
Price to earnings Ratio -
1Y Target Price 16.38
Dividends yield (FY) -
Basic EPS (TTM) -1.14
Volume (30-day avg) 54065
Beta 1.58
52 Weeks Range 8.60 - 17.82
Updated Date 11/20/2024

Earnings Date

Report Date 2024-11-07
When AfterMarket
Estimate 0.01
Actual -0.21
Report Date 2024-11-07
When AfterMarket
Estimate 0.01
Actual -0.21

Profitability

Profit Margin -13.95%
Operating Margin (TTM) 2.02%

Management Effectiveness

Return on Assets (TTM) 2.01%
Return on Equity (TTM) -60.46%

Revenue by Products

Revenue by Products - Current and Previous Year

Valuation

Trailing PE -
Forward PE 25.45
Enterprise Value 152757267
Price to Sales(TTM) 1.36
Enterprise Value to Revenue 1.26
Enterprise Value to EBITDA 21.11
Shares Outstanding 14983600
Shares Floating 10741450
Percent Insiders 1.79
Percent Institutions 73.22
Trailing PE -
Forward PE 25.45
Enterprise Value 152757267
Price to Sales(TTM) 1.36
Enterprise Value to Revenue 1.26
Enterprise Value to EBITDA 21.11
Shares Outstanding 14983600
Shares Floating 10741450
Percent Insiders 1.79
Percent Institutions 73.22

Analyst Ratings

Rating 4
Target Price 19.88
Buy 1
Strong Buy 2
Hold 2
Sell -
Strong Sell -
Rating 4
Target Price 19.88
Buy 1
Strong Buy 2
Hold 2
Sell -
Strong Sell -

AI Summarization

The Joint Corp.: A Comprehensive Overview

This report provides a comprehensive analysis of The Joint Corp. (JYNT), covering its history, products, market, financials, growth, competitors, and future potential.

Company Profile:

History and Background:

The Joint Corp. was founded in 1999 in Scottsdale, Arizona. It started as a single chiropractic clinic offering affordable and convenient chiropractic care. The company's franchising model began in 2002, and it has since grown to become the largest chiropractic franchise in the world. As of November 2023, The Joint has over 700 clinics across the United States.

Core Business Areas:

The Joint Corp. focuses on providing accessible and affordable chiropractic care through its network of franchised clinics. Its core business areas include:

  • Chiropractic Adjustments: The Joint offers a variety of chiropractic adjustments to address various musculoskeletal conditions.
  • Massage Therapy: The Joint also provides massage therapy services to help patients relax and manage pain.
  • Other Wellness Services: The Joint offers additional wellness services such as nutritional counseling and injury prevention workshops.

Leadership Team and Corporate Structure:

The Joint Corp. is led by CEO Peter D. Holt, who has been with the company since 2010. The executive team also includes President and COO Peter J. Levesque and CFO Michael R. Lonergan. The company's corporate structure is based on a franchising model, with individual clinics owned and operated by franchisees.

Top Products and Market Share:

The Joint's primary product is chiropractic care, delivered through in-office adjustments. The company's market share in the U.S. chiropractic market is estimated to be around 10%. The company also offers massage therapy and other wellness services, which contribute to its overall market share.

Total Addressable Market:

The total addressable market for chiropractic care in the U.S. is estimated to be around $15 billion. The market is expected to grow steadily in the coming years, driven by factors such as an aging population and increasing awareness of the benefits of chiropractic care.

Financial Performance:

Recent Financial Statements:

The Joint Corp. reported revenue of $187.4 million for the fiscal year ended December 31, 2022. Net income was $17.2 million, with earnings per share of $0.46. The company's profit margin was 9.2%.

Year-over-Year Comparison:

The Joint Corp.'s revenue has grown steadily in recent years. In 2022, revenue increased by 12.4% compared to the previous year. Net income and earnings per share also increased year-over-year.

Cash Flow and Balance Sheet:

The Joint Corp. has a strong cash flow position, with operating cash flow of $30.4 million in 2022. The company's balance sheet is also healthy, with total assets of $227.5 million and total liabilities of $108.7 million.

Dividends and Shareholder Returns:

The Joint Corp. does not currently pay dividends. The company's total shareholder return over the past year was 12.5%.

Growth Trajectory:

Historical Growth:

The Joint Corp. has experienced strong historical growth. The company's revenue has grown at a compound annual growth rate (CAGR) of 15% over the past five years.

Future Growth Projections:

The Joint Corp. is expected to continue its growth trajectory in the coming years. The company's management team projects revenue growth of 10-15% in 2023.

Recent Initiatives:

The Joint Corp. is investing in several growth initiatives, including opening new clinics, expanding its service offerings, and developing new technology-based solutions.

Market Dynamics:

Industry Trends:

The chiropractic industry is expected to grow steadily in the coming years, driven by factors such as an aging population and increasing awareness of the benefits of chiropractic care.

Demand-Supply Scenario:

The demand for chiropractic care is expected to continue to increase in the coming years. However, the supply of qualified chiropractors is limited, which could create challenges for the industry.

Technological Advancements:

The chiropractic industry is increasingly adopting new technologies, such as telemedicine and wearable devices, to enhance patient care and improve efficiency.

The Joint Corp.'s Positioning:

The Joint Corp. is well-positioned to benefit from the growth of the chiropractic industry. The company's franchise model allows it to scale rapidly and open new clinics in new markets. The Joint also offers a convenient and affordable alternative to traditional chiropractic care, which makes it appealing to a wide range of consumers.

Competitors:

The Joint Corp.'s main competitors include:

  • Chiropractic Health Center (CCHC): CCHC is a privately held company that operates over 300 chiropractic clinics in the United States.
  • The Genesis Group: The Genesis Group is a publicly traded company that operates over 150 chiropractic clinics in the United States.
  • ACU-Life: ACU-Life is a franchise-based chiropractic company that operates over 100 clinics in the United States.

Competitive Advantages and Disadvantages:

Advantages:

  • Largest chiropractic franchise network in the U.S.
  • Strong brand recognition:
  • Convenient and affordable care:
  • Technology-enabled platform:

Disadvantages:

  • Limited service offerings compared to some competitors:
  • Reliance on franchisees for growth:
  • Exposure to regulatory changes in the healthcare industry:

Potential Challenges and Opportunities:

Challenges:

  • Competition from other chiropractic providers:
  • Rising healthcare costs:
  • Changing consumer preferences:

Opportunities:

  • Expansion into new markets:
  • Development of new service offerings:
  • Adoption of new technologies:
  • Partnerships with other healthcare providers:

Recent Acquisitions:

The Joint Corp. has not made any acquisitions in the past three years.

AI-Based Fundamental Rating:

Rating: 7/10

The Joint Corp. receives a rating of 7/10 based on its strong financial performance, market position, and future growth prospects. The company's franchise model allows it to scale rapidly and open new clinics in new markets. The Joint also offers a convenient and affordable alternative to traditional chiropractic care, which makes it appealing to a wide range of consumers.

Sources and Disclaimers:

This report was prepared using information from the following sources:

  • The Joint Corp. website
  • The Joint Corp. annual report
  • The Joint Corp. press releases
  • Market research reports

This report is for informational purposes only and should not be considered investment advice. Please consult with a financial advisor before making any investment decisions.

Disclaimer:

The information provided in this report is based on publicly available information and should not be considered a substitute for professional financial advice. It is important to note that the stock market is volatile and past performance is not indicative of future results.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About The Joint Corp

Exchange NASDAQ Headquaters Scottsdale, AZ, United States
IPO Launch date 2014-11-11 CEO, President & Director Mr. Sanjiv Razdan
Sector Healthcare Website https://www.thejoint.com
Industry Medical Care Facilities Full time employees 444
Headquaters Scottsdale, AZ, United States
CEO, President & Director Mr. Sanjiv Razdan
Website https://www.thejoint.com
Website https://www.thejoint.com
Full time employees 444

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​